Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma

被引:118
作者
Sawatsubashi, M
Yamada, T
Fukushima, N
Mizokami, H
Tokunaga, O
Shin, T
机构
[1] Saga Med Sch, Dept Otolaryngol Head & Neck Surg, Saga 8498501, Japan
[2] Saga Med Sch, Dept Cardiovasc Surg, Saga 8498501, Japan
[3] Saga Med Sch, Dept Pathol, Saga 8498501, Japan
关键词
VEGF; angiogenesis; mast cell; macrophage; laryngeal squamous cell carcinoma;
D O I
10.1007/s004280050037
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We investigated the expression of vascular endothelial growth factor (VEGF) and microvascular density in 54 cases of invasive laryngeal squamous cell carcinoma (SCC) and in ten samples of normal laryngeal tissue using immunohistochemistry methods. The study also focused on the distribution of mast cells in and around the SCCs. The microvascular density in laryngeal carcinoma tissue was higher than that in normal tissue (P=0.02). VEGF was localized in SCCs, stromal cells, endothelial cells, minor salivary glands, and non-cancer epithelium adjacent to the tumor. VEGF expression in the tumor cells was found in 13 of 54 cases (24.1%), whereas mast cells around the carcinomas were VEGF positive in all 54 cases. Staining of VEGF in SCCs was strong in the area of high microvascular density (P=0.0002). Using a multi-labeling subtraction immunostaining method, VEGF-positive stromal cells were classified mostly as mast cells and, in a few instances, as macrophages. VEGF staining in SCCs was associated with the mast cell count (P=0.0001). There was no distinct correlation between VEGF expression and pTNM stage of an SCC. In conclusion, the results suggest that VEGF might be an important angiogenic factor in cancer invasion. Laryngeal cancer cells and mast cells may control the angiogenic response by releasing VEGF.
引用
收藏
页码:243 / 248
页数:6
相关论文
共 35 条
[1]  
Alcalde RE, 1997, ONCOLOGY, V54, P324
[2]   EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) AND ITS RECEPTORS IN BREAST-CANCER [J].
BROWN, LF ;
BERSE, B ;
JACKMAN, RW ;
TOGNAZZI, K ;
GUIDI, AJ ;
DVORAK, HF ;
SENGER, DR ;
CONNOLLY, JL ;
SCHNITT, SJ .
HUMAN PATHOLOGY, 1995, 26 (01) :86-91
[3]  
BROWN LF, 1993, CANCER RES, V53, P4727
[4]  
Denhart BC, 1997, LAB INVEST, V77, P659
[5]  
DVORAK HF, 1995, AM J PATHOL, V146, P1029
[6]   DISTRIBUTION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) IN TUMORS - CONCENTRATION IN TUMOR BLOOD-VESSELS [J].
DVORAK, HF ;
SIOUSSAT, TM ;
BROWN, LF ;
BERSE, B ;
NAGY, JA ;
SOTREL, A ;
MANSEAU, EJ ;
VANDEWATER, L ;
SENGER, DR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (05) :1275-1278
[7]   INTRATUMORAL MICROVESSEL DENSITY AND P53 PROTEIN - CORRELATION WITH METASTASIS IN HEAD-AND-NECK SQUAMOUS-CELL CARCINOMA [J].
GASPARINI, G ;
WEIDNER, N ;
MALUTA, S ;
POZZA, F ;
BORACCHI, P ;
MEZZETTI, M ;
TESTOLIN, A ;
BEVILACQUA, P .
INTERNATIONAL JOURNAL OF CANCER, 1993, 55 (05) :739-744
[8]  
GLOWACKI J, 1982, PEDIATRICS, V70, P48
[9]   Synthesis, storage, and release of vascular endothelial growth factor vascular permeability factor (VEGF/VPF) by human mast cells:: Implications for the biological significance of VEGF206 [J].
Grützkau, A ;
Krüger-Krasagakes, S ;
Baumeister, H ;
Schwarz, C ;
Kögel, H ;
Welker, P ;
Lippert, U ;
Henz, BM ;
Möller, A .
MOLECULAR BIOLOGY OF THE CELL, 1998, 9 (04) :875-884
[10]  
Guidi AJ, 1997, CANCER, V80, P1945, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1945::AID-CNCR11>3.0.CO